MLL5/KMT2E anticorps
Aperçu rapide pour MLL5/KMT2E anticorps (ABIN7261988)
Antigène
Voir toutes MLL5/KMT2E (MLL5) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human KMT2E (NP_061152.3).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:50-1:200 IF 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
-
Autre désignation
- KMT2E
-
Sujet
- This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a protein with an N-terminal PHD zinc finger and a central SET domain. Overexpression of the protein inhibits cell cycle progression. Alternate transcriptional splice variants have been characterized.
-
ID gène
- 55904
-
UniProt
- Q8IZD2
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, L'effet Warburg
Antigène
-